HHS Secretary Robert F. Kennedy Jr. has responded to criticism from activists after extending liability protections for drugmakers developing treatments for the Andes hantavirus strain. The protections, which apply to the antiviral drug favipiravir, were announced on May 26, 2026, and will last until July 18.
Our neutral summary
HHS Secretary Robert F. Kennedy Jr. has responded to criticism from activists after extending liability protections for drugmakers developing treatments for the Andes hantavirus strain. The protections, which apply to the antiviral drug favipiravir, were announced on May 26, 2026, and will last until July 18.
The reporting belongs to The Hill; we don't reproduce it.
No note attached
on this article.
Kennedy faces anti-vaccine anger over hantavirus treatment legal protections
HHS Secretary Kennedy Responds to Criticism Over Hantavirus Treatment Liability Protections